Impact of the timing of capsule endoscopy in overt obscure gastrointestinal bleeding on yield and rebleeding rate - is sooner than 14 d advisable?

Table 3 Capsule endoscopy findings in all patients and between ≤ 48 h, 48 h-14 d and ≥ 14 d group n (%)

	All (n = 115)	≤ 48 h (n = 39)	48 h-14 d (n = 35)	≥ 14 d (n = 41)	P value1
Total enteroscopy	104 (90.4)	33 (84.6)	32 (91.4)	39 (95.1)	0.27
Appropriate cleansing	87 (75.7)	21 (53.8)	31 (88.6)	35 (85.4)	0.00
Positive Findings	94 (81.8)	33 (84.3)	31 (88.6)	31 (75.6)	0.30
Angiodysplasia	30 (26.1)	6 (15.4)	11 (31.4)	13 (31.7)
Varices	1 (0.9)	0	1 (2.9)	0
Hemangioma	3 (2.6)	1 (2.6)	1 (2.9)	1 (2.4)
Ulcers	12 (10.4)	3 (7.7)	5 (14.3)	4 (9,8)
Erosions	7 (6)	1 (2.6)	1 (2.9)	5 (12.2)
Tumours	11 (9.6)	2 (5.1)	7 (20)	2 (4.9)
Polyps	4 (3.5)	1 (2.6)	2 (5.7)	1 (2.4)
Diverticula	2 (1.7)	1 (2.6)	0	1 (2.4)
Extra-SB cause	2 (1.7)	2 (5.1)	0	0
Bleeding	48 (41.7)	23 (59)	15 (42.9)	10 (24.4)	0.007
Inactive bleeding	13 (11.3)	6 (15.4)	5 (14.3)	2 (4.9)	0.27
Active bleeding	35 (30.4)	17 (43.6)	10 (28.6)	8 (19.5)	0.06

¹χ² test; P value of 0.05 indicating statistical significance. CE: Capsule endoscopy.